EN DE

Givaudan SA (GIVN) Fair Value & Analysis

Basic Materials · CH · Market cap CHF 31.3B

GS Givaudan SA GIVN · SW
PriceCHF 3,378
Fair ValueCHF 1,498
Upside-55.7%
Quality70/100
Watch Givaudan SA for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 14.3% net margin
Moderate debt · generates free cash flow
2.13% dividend yield
Mixed vs. peers (6/15)
Wide moat 66/100
Evidence: High Range CHF 1,051 – CHF 2,195 Share as image

Fair value as of: Jul 16, 2026

From 25 valuation models · updated 25 days ago

Share price −1.6% over the past month.

A solid business, but screening 56% overvalued on our models.

What matters now

  • A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case (CHF 2,195). The favourable scenario is already priced in.
  • A fairly wide model range (CHF 1,051 to CHF 2,195) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

CHF 4,463 CHF 2,507 Fair Value CHF 1,498 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range CHF 2,507 – CHF 4,463 · fair‑value band CHF 1,051 – CHF 2,195 · the CHF 3,378 price screens above the CHF 1,498 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Givaudan SA (GIVN) currently trades at CHF 3,378, while our model-based Fair Value estimate is CHF 1,498, implying the stock looks roughly 55.7% overvalued today. The Quality Score stands at 70/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Givaudan SA generated revenue of CHF 7.5B at a net margin of 14.3%. Revenue declined 1.8% year over year. It earns a return on equity of 23.4%. Net debt stands at CHF 3.7B. Fundamentals as of Jul 16, 2026

Our scenario range runs from CHF 1,051 (bear case) to CHF 2,195 (bull case); at CHF 3,378, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 18% below its 52-week high and 32% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -56%, GIVN screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF CHF 1,127 CHF 1,760 CHF 2,641 80
Residual Income CHF 720.51 CHF 896.91 CHF 2,953 76
Rev-Margin DCF CHF 689.58 CHF 1,177 CHF 1,719 74
All 25 models by family
DCF Models
FCF DCF CHF 1,092 CHF 1,786 CHF 2,803 38
Owner Earnings CHF 1,007 CHF 1,660 CHF 2,616 31
5Y Revenue Exit CHF 689.58 CHF 1,160 CHF 1,736 39
5Y EBITDA Exit CHF 979.05 CHF 1,685 CHF 2,480 41
5Y P/E Exit CHF 1,012 CHF 1,744 CHF 2,484 38
10Y Revenue Exit CHF 800.14 CHF 1,254 CHF 1,818 36
10Y EBITDA Exit CHF 1,007 CHF 1,613 CHF 2,370 37
10Y P/E Exit CHF 1,028 CHF 1,653 CHF 2,373 35
Earnings-Based
Graham-Dodd CHF 789.10 CHF 2,083 CHF 2,721 54
PEG = 1.0 CHF 400.47 CHF 572.10 CHF 743.73 46
EPV CHF 847.40 CHF 1,045 CHF 1,217 59
Dividend Discount
Gordon GGM CHF 641.69 CHF 1,317 CHF 2,117 70
DDM Multi-Stage CHF 641.69 CHF 991.39 CHF 1,366 61
Multiples
P/E Multiple CHF 1,480 CHF 1,973 CHF 2,466 63
P/S Multiple CHF 910.81 CHF 1,214 CHF 1,518 58
P/B Multiple CHF 1,106 CHF 1,475 CHF 1,843 55
EV/EBIT CHF 1,235 CHF 1,759 CHF 2,282 53
EV/EBITDA CHF 1,086 CHF 1,560 CHF 2,034 54
EV/Revenue CHF 513.87 CHF 878.19 CHF 1,243 43
Asset-Based
NCAV (Graham) CHF 245.80 CHF 329.37 CHF 491.59 50
Growth DCF
Growth DCF CHF 1,127 CHF 1,760 CHF 2,641 80
Rev-Margin DCF CHF 689.58 CHF 1,177 CHF 1,719 74
Economic Profit
Residual Income CHF 720.51 CHF 896.91 CHF 2,953 76
ROIC Compounder CHF 901.07 CHF 1,208 CHF 1,564 72
Growth Earnings
Growth-Adj P/E CHF 1,182 CHF 1,689 CHF 2,195 68

Widest divergence: Growth Earnings (CHF 1,689) versus Asset-Based (CHF 329.37). Highest evidence: Growth DCF (80).

Notify me when GIVN reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) CHF 7.5B
Revenue growth (YoY) -1.8%
Net margin 14.3%
Return on equity 23.4%
Free cash flow CHF 1.2B FY2025
P/E ratio 25.1
More key figures
Operating margin 16.9%
EPS (TTM) CHF 115.42
Dividend yield 2.5%
EPS growth (YoY) -4.7%
Net debt CHF 3.7B FY2025

Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 70/100

Of which business quality 66 · Market factors (momentum, volatility) 63

Profitability 59
Margins and returns on capital today
Quality Growth 44
Are margins and returns improving?
Cashflow 70
Earnings quality: real cash, not paper profit
Fin. Strength 62
Balance sheet, leverage, solvency risk
Investment 91
Disciplined investing over empire-building
Low Volatility 83
Calm price path (market factor)
Momentum 55
Price trend over the last 3–12 months (market factor)
52W Momentum 52
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing.

Full company description

Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Givaudan SA reported revenue of CHF 7.5B in FY2025 versus CHF 6.7B in FY2021, a compound +2.8%/yr. Reported net income was CHF 1.1B in FY2025, compounding +6.9%/yr from FY2021.

Growth Quality 75/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
CHF 7.5B
Latest YoY
+0.8%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.4%
Avg. growth/yr (23Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.6%
Revenue +2.8%/yr
FY21 CHF 6.7B
FY22 CHF 7.1B
FY23 CHF 6.9B
FY24 CHF 7.4B
FY25 CHF 7.5B
Net income +6.9%/yr
FY21 CHF 821M
FY22 CHF 856M
FY23 CHF 893M
FY24 CHF 1.1B
FY25 CHF 1.1B
Character of growth · EPS growth decomposed (2014-2025) +5.8 % p.a.
Revenue per share +5.6 pp

of which total revenue +5.5 pp · buybacks/dilution +0.1 pp

EBIT margin +0.6 pp
Tax rate +0.0 pp
Residual (interest, one-offs) −0.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

GIVN screens 56% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Givaudan SA Fair Value". https://www.fairvalue-calculator.com/stock/GIVN

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 70 · Top 25%
Fair Value upside −56% · Below median
Return on equity (TTM) 23% · Top 25%
Return on assets 7% · Top 25%
Net margin (TTM) 14% · Top 25%
Operating margin (TTM) 17% · Top 25%
Revenue growth -2% · Below median
Dividend yield (TTM) 2.1% · Above median
Debt / equity 0.85× · Higher than 75% of peers

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 29.4× · Pricier than median
P/B 8.53× · Pricier than 75% of peers
P/S (TTM) 5.18× · Pricier than 75% of peers
P/FCF 32.1× · Pricier than 75% of peers
EV/EBITDA 25.8× · Pricier than 75% of peers
PEG 4.87× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 19
PAST 94 · sector 23
HEALTH 58 · sector 95
DIVIDEND 43 · sector 25

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Givaudan SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Givaudan SA (GIVN) overvalued or undervalued?
As of Jul 16, 2026, our model estimates a fair value of CHF 1,498 versus a price of CHF 3,378, about −56% (overvalued).
What is the fair value of GIVN?
Our model-based fair value for Givaudan SA is CHF 1,498 (as of Jul 16, 2026), built from audited fundamentals. The current price is CHF 3,378.
What is the quality score of GIVN?
Givaudan SA has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Givaudan SA (GIVN)?
Givaudan SA reported trailing-twelve-month revenue of about CHF 7.5B (latest available figure, as of Jul 16, 2026).
What is the net profit margin of GIVN?
The net profit margin of Givaudan SA is about 14.3%, meaning it keeps roughly 14.3% of revenue as net income. Based on the latest reported figures.
Does Givaudan SA pay a dividend?
Givaudan SA currently shows a dividend yield of about 2.46% relative to its recent price (as of Jul 16, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Givaudan SA and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.